ANNX compared with SLN: revenue, margins and what each company keeps, and the suppliers and customers both name

ANNXAnnexon, Inc.

Mkt capRevenueRevenue

SLNSilence Therapeutics plc

Mkt capRevenueRevenue

Compare

ANNXAnnexon, Inc.

SLNSilence Therapeutics plc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

ANNX

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±11.9%▼−0.19%×0.02

May 8 '26±53.1%▲+3.08%×0.06

Q1 FY26±13.7%▲+11.69%×0.85

Q3 FY25±15.8%▼−0.34%×0.02

SLN

No earnings history for SLN.

= impliedANNX realized, solidSLN realized, hatchedOne scale, both sides: full bar = 54%× = |realized| ÷ impliedSource: market data

ANNXAnnexon, Inc.

4.21▲+4.99%· post 4.21

Mkt cap$858.7MRevenue—Revenue—

SLNSilence Therapeutics plc

19.73▲+0.03%· post 19.73

ClosedNov 6 '26

Mkt cap$932.2MRevenue$422,000Q1 FY26Revenue$559,000FY25

Compare

ClosedNov 6 '26

ANNXAnnexon, Inc.

SLNSilence Therapeutics plc

4.21▲+4.99%post 4.21

Price

19.73▲+0.03%post 19.73

$858.7M

Mkt cap

$932.2M

—

Revenue

$422,000Q1 FY26

—

Revenue

$559,000FY25

ANNX4.21▲+4.99%vsSLN19.73▲+0.03%ClosedNov 6 '26